Header Logo

Jonathan Kay

Concepts (522)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Biosimilar Pharmaceuticals
27
2023
28
13.060
Why?
Arthritis, Rheumatoid
53
2025
322
11.570
Why?
Antirheumatic Agents
42
2025
214
9.100
Why?
Rheumatic Diseases
15
2025
38
4.800
Why?
Rheumatology
17
2025
66
4.760
Why?
Nephrogenic Fibrosing Dermopathy
17
2016
22
4.460
Why?
Contrast Media
16
2016
408
3.330
Why?
Gadolinium
14
2016
103
3.200
Why?
Spondylarthritis
11
2024
40
2.830
Why?
Arthritis, Psoriatic
9
2025
33
2.780
Why?
Spondylitis, Ankylosing
9
2024
24
2.630
Why?
Antibodies, Monoclonal
20
2025
839
2.510
Why?
Infliximab
12
2022
49
2.400
Why?
Methotrexate
15
2021
76
2.160
Why?
Adalimumab
9
2023
30
1.520
Why?
Humans
145
2025
59360
1.510
Why?
Kidney Failure, Chronic
12
2010
206
1.380
Why?
Drug Approval
6
2020
25
1.290
Why?
Double-Blind Method
20
2022
715
1.230
Why?
Skin Diseases
6
2016
76
1.080
Why?
United States Food and Drug Administration
3
2024
85
1.080
Why?
Joints
4
2017
32
1.070
Why?
Tumor Necrosis Factor-alpha
13
2025
588
1.050
Why?
Skin
10
2016
357
1.010
Why?
Gadolinium DTPA
4
2016
84
0.950
Why?
Treatment Outcome
26
2025
5284
0.910
Why?
Fibrosis
8
2013
153
0.880
Why?
Therapeutic Equivalency
5
2022
16
0.810
Why?
Crohn Disease
1
2023
106
0.800
Why?
Middle Aged
47
2024
16317
0.790
Why?
Biological Therapy
4
2019
16
0.780
Why?
Male
57
2024
27739
0.770
Why?
Arthritis
2
2020
49
0.760
Why?
Vasculitis
4
2024
50
0.740
Why?
Severity of Illness Index
16
2017
1479
0.730
Why?
Female
60
2024
30705
0.730
Why?
Azetidines
1
2020
7
0.710
Why?
Bone and Bones
3
2016
137
0.700
Why?
Adult
40
2024
15669
0.690
Why?
Hematologic Agents
1
2020
3
0.690
Why?
Filgrastim
1
2020
6
0.690
Why?
Scleroderma, Systemic
3
2016
20
0.640
Why?
Patient Care Management
1
2019
30
0.640
Why?
Magnetic Resonance Imaging
9
2019
2060
0.640
Why?
Practice Guidelines as Topic
6
2024
705
0.630
Why?
Kidney Diseases
3
2011
169
0.610
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2024
202
0.600
Why?
Clinical Decision-Making
1
2019
146
0.600
Why?
Academic Medical Centers
1
2020
306
0.590
Why?
Spondylarthropathies
2
2019
4
0.590
Why?
Amyloidosis
9
2008
62
0.580
Why?
United States
11
2024
7390
0.560
Why?
Organometallic Compounds
3
2016
63
0.550
Why?
Renal Insufficiency, Chronic
4
2014
114
0.550
Why?
Acquired Hyperostosis Syndrome
1
2016
1
0.540
Why?
Biological Products
3
2024
90
0.540
Why?
Osteoarthritis
3
2024
131
0.530
Why?
C-Reactive Protein
5
2019
159
0.520
Why?
Acute-Phase Proteins
2
2014
34
0.520
Why?
United States Department of Veterans Affairs
1
2020
519
0.520
Why?
Antibodies, Monoclonal, Humanized
7
2025
219
0.510
Why?
Immunologic Factors
4
2015
103
0.510
Why?
Exercise
2
2020
883
0.510
Why?
Surveys and Questionnaires
5
2022
2513
0.500
Why?
Molecular Targeted Therapy
4
2025
121
0.490
Why?
Aged
28
2019
13416
0.490
Why?
beta 2-Microglobulin
10
2001
48
0.470
Why?
Macrophages
4
2014
1015
0.460
Why?
Meglumine
2
2016
18
0.460
Why?
Peritoneum
1
2014
27
0.460
Why?
Hypophosphatemia
1
2014
6
0.450
Why?
Peritonitis
1
2014
35
0.450
Why?
Cryoglobulinemia
2
2005
3
0.450
Why?
Blood Sedimentation
1
2014
7
0.450
Why?
Immunoglobulin G
4
2018
446
0.440
Why?
Polychondritis, Relapsing
1
2013
3
0.430
Why?
Remission Induction
8
2019
137
0.430
Why?
Gastrointestinal Diseases
2
2013
69
0.420
Why?
Rare Diseases
1
2013
38
0.410
Why?
Injections, Subcutaneous
6
2021
69
0.410
Why?
Interleukin-1beta
1
2014
258
0.400
Why?
Risk Factors
11
2018
4984
0.400
Why?
Global Health
1
2013
167
0.400
Why?
Myelodysplastic Syndromes
1
2013
75
0.390
Why?
Piperazines
2
2011
74
0.380
Why?
Renal Insufficiency
2
2009
65
0.380
Why?
Drug Therapy, Combination
8
2021
452
0.380
Why?
Pyrimidines
2
2011
131
0.370
Why?
Drugs, Generic
1
2011
16
0.370
Why?
Neoplasms
3
2022
1240
0.360
Why?
Kidney
4
2016
416
0.360
Why?
Protein Kinase Inhibitors
2
2011
172
0.360
Why?
Glycation End Products, Advanced
5
2003
18
0.360
Why?
Bursitis
1
2010
13
0.350
Why?
Area Under Curve
3
2021
141
0.350
Why?
Inflammasomes
1
2014
324
0.350
Why?
Renal Dialysis
6
2000
189
0.350
Why?
Diabetes Complications
1
2010
100
0.340
Why?
Societies, Medical
5
2024
338
0.340
Why?
Comorbidity
5
2013
1078
0.330
Why?
Autopsy
1
2009
53
0.330
Why?
Carrier Proteins
1
2014
697
0.330
Why?
Cost Savings
2
2020
52
0.320
Why?
Randomized Controlled Trials as Topic
4
2022
677
0.320
Why?
Lupus Erythematosus, Systemic
3
2025
158
0.320
Why?
Software
2
2009
367
0.310
Why?
Medical Records Systems, Computerized
1
2009
60
0.310
Why?
Terminology as Topic
6
2016
133
0.310
Why?
Cohort Studies
5
2023
2374
0.300
Why?
Diagnosis, Differential
7
2016
937
0.300
Why?
Teriparatide
2
2018
6
0.290
Why?
Pulmonary Fibrosis
1
2008
79
0.280
Why?
Dose-Response Relationship, Drug
9
2019
806
0.280
Why?
Tomography, X-Ray Computed
7
2022
1526
0.280
Why?
Quality of Life
6
2024
1137
0.280
Why?
Disease Progression
6
2017
1122
0.280
Why?
Back Pain
3
2022
48
0.270
Why?
Radiography
4
2017
517
0.270
Why?
Prevalence
5
2013
1252
0.260
Why?
Qualitative Research
5
2022
618
0.260
Why?
Temporal Arteries
1
2006
4
0.260
Why?
Receptors, Immunologic
5
2003
176
0.260
Why?
Giant Cell Arteritis
1
2006
5
0.260
Why?
Databases, Factual
4
2024
813
0.260
Why?
Cardiovascular Diseases
1
2013
788
0.260
Why?
Clinical Trials as Topic
2
2024
441
0.260
Why?
Glomerulonephritis, Membranoproliferative
1
2005
5
0.250
Why?
Attitude of Health Personnel
2
2009
550
0.250
Why?
Antibodies, Antinuclear
2
2018
36
0.250
Why?
Interleukin-1
3
2004
157
0.240
Why?
Monocytes
4
2001
345
0.230
Why?
Internationality
2
2015
43
0.230
Why?
Healthy Volunteers
2
2021
66
0.220
Why?
Drug Industry
3
2018
39
0.220
Why?
Biomedical Research
2
2017
256
0.220
Why?
Hospitals, General
1
2023
13
0.220
Why?
Rituximab
3
2017
80
0.220
Why?
Massachusetts
3
2023
2002
0.210
Why?
Physicians, Primary Care
2
2021
72
0.210
Why?
Drug Costs
2
2020
54
0.210
Why?
Gout
2
2016
48
0.200
Why?
Inflammation
2
2021
1099
0.200
Why?
Ultrasonography
2
2016
459
0.200
Why?
Psoriasis
1
2022
50
0.190
Why?
Europe
5
2015
184
0.190
Why?
Lymphoproliferative Disorders
1
2002
38
0.190
Why?
Dopamine
1
2022
102
0.190
Why?
Patient Care Planning
2
2019
84
0.190
Why?
Graft vs Host Disease
1
2022
105
0.190
Why?
Drug Substitution
3
2025
40
0.180
Why?
Health Knowledge, Attitudes, Practice
3
2019
724
0.180
Why?
Republic of Korea
1
2021
29
0.180
Why?
Depression, Postpartum
1
2023
129
0.180
Why?
Hyperpigmentation
2
2012
6
0.180
Why?
Janus Kinase 1
1
2020
10
0.180
Why?
Janus Kinase 2
1
2020
14
0.180
Why?
Purines
1
2020
38
0.180
Why?
Philadelphia
1
2020
19
0.170
Why?
Medicare Part B
1
2020
10
0.170
Why?
Fatal Outcome
3
2009
116
0.170
Why?
Attitude
1
2020
96
0.170
Why?
Pyrazoles
1
2020
65
0.170
Why?
Legislation, Drug
1
2020
17
0.170
Why?
Synovial Fluid
2
1991
29
0.170
Why?
Hepatitis C
1
2002
143
0.170
Why?
European Union
1
2020
11
0.170
Why?
Reimbursement Mechanisms
1
2020
40
0.170
Why?
Iatrogenic Disease
1
2000
58
0.170
Why?
Personality Disorders
1
1999
19
0.170
Why?
Retrospective Studies
7
2024
6071
0.170
Why?
Disability Evaluation
2
2012
199
0.170
Why?
Infusions, Intravenous
1
2020
164
0.170
Why?
Observational Studies as Topic
1
2020
55
0.170
Why?
Benzamides
2
2011
63
0.160
Why?
Gastroenterology
1
2020
35
0.160
Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
57
0.160
Why?
Sulfonamides
1
2020
121
0.160
Why?
Risk Assessment
3
2019
1921
0.160
Why?
Patient Acuity
1
2019
19
0.160
Why?
Sacroiliitis
1
2019
1
0.160
Why?
Patient Participation
2
2019
216
0.160
Why?
Biopsy
4
2011
411
0.160
Why?
Certolizumab Pegol
1
2019
2
0.160
Why?
Lyme Disease
2
1993
104
0.160
Why?
Reproducibility of Results
4
2022
1561
0.160
Why?
Animals
11
2022
19651
0.160
Why?
Evidence-Based Medicine
3
2017
442
0.160
Why?
Pain
4
2024
396
0.160
Why?
Prospective Studies
3
2025
3067
0.160
Why?
Polyethylene Glycols
1
2020
165
0.150
Why?
Data Mining
1
2019
35
0.150
Why?
Cost-Benefit Analysis
1
2020
297
0.150
Why?
Consensus
2
2017
193
0.150
Why?
Glucocorticoids
2
2013
179
0.150
Why?
Guideline Adherence
3
2024
290
0.150
Why?
Anti-Citrullinated Protein Antibodies
1
2018
6
0.150
Why?
Aged, 80 and over
6
2011
5128
0.150
Why?
Motivation
1
2020
273
0.140
Why?
Bone Diseases, Metabolic
1
2017
19
0.140
Why?
Case-Control Studies
3
2018
1051
0.140
Why?
Health Services Needs and Demand
1
2019
203
0.140
Why?
Time Factors
9
2025
3617
0.140
Why?
Cigarette Smoking
1
2018
53
0.140
Why?
Lymphoma
1
2018
99
0.140
Why?
Bipolar Disorder
1
1999
243
0.140
Why?
Bone Density Conservation Agents
1
2017
44
0.140
Why?
Delayed Diagnosis
3
2022
42
0.140
Why?
Review Literature as Topic
2
2016
33
0.140
Why?
Snail Family Transcription Factors
1
2016
28
0.140
Why?
Biomarkers
4
2024
1306
0.140
Why?
Bone Density
1
2017
129
0.130
Why?
Social Media
1
2019
117
0.130
Why?
Radionuclide Imaging
1
2016
121
0.130
Why?
Alcoholism
1
1999
309
0.130
Why?
Uric Acid
1
2016
45
0.130
Why?
Physicians
1
2021
435
0.130
Why?
Young Adult
3
2024
4267
0.130
Why?
Positron Emission Tomography Computed Tomography
1
2016
44
0.130
Why?
Hand Bones
1
2016
1
0.130
Why?
Heterocyclic Compounds
1
2016
12
0.130
Why?
Drug Design
1
2017
137
0.130
Why?
Hedgehog Proteins
1
2016
109
0.130
Why?
Mass Screening
1
2021
645
0.130
Why?
Hand Joints
1
2016
21
0.120
Why?
International Agencies
1
2015
7
0.120
Why?
Predictive Value of Tests
2
2009
1025
0.120
Why?
Biological Availability
1
2016
195
0.120
Why?
China
2
2015
134
0.120
Why?
Drug Monitoring
1
2015
115
0.120
Why?
Bone Resorption
2
2016
41
0.120
Why?
Creatinine
3
2011
128
0.120
Why?
Advisory Committees
1
2015
108
0.110
Why?
Health Status
2
2021
424
0.110
Why?
Fibronectins
2
1991
43
0.110
Why?
CARD Signaling Adaptor Proteins
1
2014
64
0.110
Why?
Inflammation Mediators
2
2013
170
0.110
Why?
Apoptosis Regulatory Proteins
1
2014
146
0.110
Why?
Caveolin 1
1
2013
7
0.110
Why?
Ear Cartilage
1
2013
7
0.110
Why?
Self Report
1
2015
359
0.100
Why?
Transforming Growth Factor beta1
1
2013
53
0.100
Why?
Scleroderma, Diffuse
1
2012
2
0.100
Why?
Raynaud Disease
1
2012
4
0.100
Why?
Quality Assurance, Health Care
1
2015
251
0.100
Why?
Osteoporosis
1
2013
102
0.100
Why?
Contracture
1
2012
8
0.100
Why?
Dexamethasone
1
1994
201
0.100
Why?
Imatinib Mesylate
2
2011
33
0.100
Why?
Hemoglobins
1
2013
133
0.100
Why?
Hydrocortisone
1
1994
187
0.100
Why?
Canada
1
2012
147
0.100
Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2014
250
0.100
Why?
Health Services Accessibility
1
2017
521
0.100
Why?
Lung Diseases
1
2013
170
0.100
Why?
Congresses as Topic
2
2025
73
0.100
Why?
Quality Indicators, Health Care
1
2015
332
0.100
Why?
Shoulder
2
2010
24
0.100
Why?
North America
4
2015
106
0.090
Why?
Arthrography
1
2011
7
0.090
Why?
Opsonin Proteins
1
1991
31
0.090
Why?
Health Care Surveys
2
2009
271
0.090
Why?
Dermis
1
2011
16
0.090
Why?
Shoulder Impingement Syndrome
1
2010
2
0.090
Why?
Immunosuppressive Agents
1
2013
365
0.090
Why?
Polymorphism, Single Nucleotide
1
2013
439
0.090
Why?
Hearing Loss, Sensorineural
1
2011
47
0.090
Why?
Adolescent
4
2016
5824
0.090
Why?
Muscular Diseases
2
2006
46
0.090
Why?
Cross-Sectional Studies
2
2015
2373
0.090
Why?
Range of Motion, Articular
1
2010
85
0.090
Why?
Risk Reduction Behavior
1
2011
121
0.090
Why?
International Cooperation
4
2010
84
0.090
Why?
Registries
1
2014
801
0.090
Why?
Cost of Illness
2
2022
156
0.090
Why?
Pain Measurement
1
2011
327
0.080
Why?
Edema
2
2009
43
0.080
Why?
Recovery of Function
1
2011
270
0.080
Why?
Pilot Projects
1
2013
914
0.080
Why?
Serum Amyloid A Protein
1
2009
7
0.080
Why?
E-Selectin
1
2009
18
0.080
Why?
Drug-Related Side Effects and Adverse Reactions
1
2011
140
0.080
Why?
Thromboembolism
1
2009
69
0.080
Why?
Medical Informatics Applications
1
2009
14
0.080
Why?
Mice, Knockout
1
2014
1994
0.080
Why?
Pregnancy
3
2023
2202
0.080
Why?
Disease Models, Animal
2
2014
2050
0.080
Why?
Interleukin-18
1
2009
71
0.080
Why?
Matrix Metalloproteinase 9
1
2009
59
0.080
Why?
Drug Eruptions
1
2008
14
0.080
Why?
Cause of Death
1
2009
210
0.080
Why?
Eosinophilia
1
1988
30
0.080
Why?
Receptors, Cell Surface
1
1991
428
0.080
Why?
Chronic Kidney Disease-Mineral and Bone Disorder
1
2008
5
0.080
Why?
Chondrocalcinosis
1
2008
3
0.080
Why?
Uremia
1
2008
9
0.080
Why?
Patient Satisfaction
1
2011
412
0.070
Why?
Peripheral Nervous System Diseases
1
2008
26
0.070
Why?
Joint Diseases
1
2008
18
0.070
Why?
Receptor for Advanced Glycation End Products
3
2003
19
0.070
Why?
Proportional Hazards Models
1
2009
674
0.070
Why?
Antineoplastic Agents
1
2013
631
0.070
Why?
Insulin Resistance
1
2011
392
0.070
Why?
Drug Resistance
1
2008
95
0.070
Why?
Syndrome
1
2007
170
0.070
Why?
Acanthamoeba
1
2006
1
0.070
Why?
Amebiasis
1
2006
1
0.070
Why?
Mice, Inbred C57BL
1
2014
3231
0.070
Why?
Shock, Septic
1
2008
86
0.070
Why?
Granuloma
1
2006
41
0.070
Why?
Pneumonia
1
2009
281
0.070
Why?
Granulomatosis with Polyangiitis
1
2006
14
0.070
Why?
Encephalitis
1
2006
34
0.070
Why?
Acute-Phase Reaction
3
2010
18
0.070
Why?
Diabetes Mellitus, Type 2
2
2011
635
0.070
Why?
Mental Disorders
1
2013
717
0.070
Why?
Synovitis
3
2010
30
0.060
Why?
Mice
3
2022
10292
0.060
Why?
Pharyngitis
1
2006
12
0.060
Why?
Myocardium
1
2008
264
0.060
Why?
Early Diagnosis
3
2010
92
0.060
Why?
Rocky Mountain Spotted Fever
1
2005
1
0.060
Why?
Knee Joint
1
2008
285
0.060
Why?
Autoantibodies
2
2018
172
0.060
Why?
Follow-Up Studies
2
2009
2337
0.060
Why?
Exanthema
1
2005
26
0.060
Why?
Prednisone
1
2005
85
0.060
Why?
Logistic Models
2
2019
1232
0.060
Why?
Pragmatic Clinical Trials as Topic
1
2025
6
0.060
Why?
Fatigue
1
2006
103
0.060
Why?
Dyspnea
1
2006
116
0.060
Why?
Clinical Trials, Phase III as Topic
1
2025
40
0.060
Why?
Multicenter Studies as Topic
1
2025
130
0.060
Why?
Interleukin-23
1
2024
19
0.060
Why?
Receptors, Interleukin-1
1
2004
66
0.060
Why?
Precision Medicine
1
2025
102
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
206
0.060
Why?
Anorexia Nervosa
1
1983
16
0.050
Why?
Research Design
2
2017
555
0.050
Why?
Rabbits
1
2004
322
0.050
Why?
Time-to-Treatment
1
2024
98
0.050
Why?
Models, Animal
1
2004
221
0.050
Why?
Collagen
3
1998
115
0.050
Why?
Epidemiologic Methods
2
2014
65
0.050
Why?
Chromosomes, Human, Pair 3
1
2002
12
0.050
Why?
Glucans
2
1994
63
0.050
Why?
Ion Channels
1
2022
88
0.050
Why?
Trisomy
1
2002
19
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
98
0.050
Why?
Etanercept
2
2013
32
0.050
Why?
Receptors, Tumor Necrosis Factor
2
2013
62
0.050
Why?
Sports Medicine
1
2021
22
0.050
Why?
Syringes
1
2021
10
0.050
Why?
Cytokines
2
2016
912
0.050
Why?
Sex Factors
1
2024
935
0.050
Why?
General Practitioners
1
2021
14
0.050
Why?
Longitudinal Studies
1
2025
1189
0.050
Why?
Phagocytosis
2
1994
260
0.050
Why?
Chronic Disease
2
2016
716
0.040
Why?
Triazoles
1
2021
51
0.040
Why?
Psychometrics
1
2022
362
0.040
Why?
Pyridines
1
2021
98
0.040
Why?
Hypertension
1
2005
568
0.040
Why?
Nutrition Surveys
1
2021
129
0.040
Why?
Psychiatric Status Rating Scales
1
1999
379
0.040
Why?
Brain
1
2006
1488
0.040
Why?
Guanidines
1
1998
14
0.040
Why?
Cognition
1
2022
455
0.040
Why?
Denmark
1
2018
16
0.040
Why?
Sweden
1
2018
42
0.040
Why?
Electronic Health Records
1
2021
342
0.040
Why?
Lymphoma, Follicular
1
2018
16
0.040
Why?
Immunoglobulin M
1
2018
114
0.040
Why?
Infant
1
2022
1486
0.040
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2018
39
0.040
Why?
Ulna
1
2017
4
0.040
Why?
Lymphoma, Non-Hodgkin
1
2018
50
0.040
Why?
Radius
1
2017
13
0.040
Why?
Metacarpophalangeal Joint
1
2017
9
0.040
Why?
Hodgkin Disease
1
2018
55
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2018
65
0.030
Why?
Immunoglobulin A
1
2018
94
0.030
Why?
Aging
1
2003
710
0.030
Why?
Medication Therapy Management
1
2017
20
0.030
Why?
Cicatrix, Hypertrophic
1
2016
1
0.030
Why?
Patched Receptors
1
2016
10
0.030
Why?
Keloid
1
2016
3
0.030
Why?
Glycogen Synthase Kinase 3 beta
1
2016
26
0.030
Why?
Membrane Proteins
1
2022
850
0.030
Why?
Health Priorities
1
2016
23
0.030
Why?
beta Catenin
1
2016
86
0.030
Why?
Carpal Tunnel Syndrome
1
1996
31
0.030
Why?
Evaluation Studies as Topic
1
1996
103
0.030
Why?
Cicatrix
1
2016
59
0.030
Why?
Fibroblasts
1
1998
377
0.030
Why?
Medicaid
1
2019
334
0.030
Why?
Cells, Cultured
3
2001
2093
0.030
Why?
Pharmacovigilance
1
2016
13
0.030
Why?
Enzyme Inhibitors
1
1998
349
0.030
Why?
Intention to Treat Analysis
1
2015
18
0.030
Why?
Odds Ratio
1
2018
745
0.030
Why?
ROC Curve
1
1996
266
0.030
Why?
Guidelines as Topic
1
2016
154
0.030
Why?
Apoptosis
1
2001
1032
0.030
Why?
Osteogenesis
1
2016
140
0.030
Why?
Primary Health Care
1
2021
643
0.030
Why?
Asia
1
2015
18
0.030
Why?
Medicare
1
2019
598
0.030
Why?
Needs Assessment
1
2016
187
0.030
Why?
Algorithms
2
2010
976
0.030
Why?
Treatment Failure
1
2015
185
0.030
Why?
Anti-Bacterial Agents
2
1993
735
0.030
Why?
Immunohistochemistry
2
1998
847
0.030
Why?
Life Style
1
2016
299
0.030
Why?
Activities of Daily Living
1
1996
289
0.030
Why?
Electrophoresis, Gel, Two-Dimensional
2
1991
39
0.030
Why?
Medication Adherence
1
2016
239
0.030
Why?
Receptors, Interleukin-6
1
2014
15
0.030
Why?
Blood Proteins
1
1994
75
0.030
Why?
Sensitivity and Specificity
1
1996
1093
0.030
Why?
Analysis of Variance
2
2009
589
0.030
Why?
Codon
1
2013
48
0.030
Why?
Gene Frequency
1
2013
118
0.030
Why?
Feasibility Studies
1
2015
525
0.030
Why?
Patient Education as Topic
1
2016
453
0.030
Why?
Drug Administration Schedule
1
2013
283
0.030
Why?
Introns
1
2013
104
0.030
Why?
Shoulder Joint
1
1992
24
0.020
Why?
Chi-Square Distribution
1
2013
409
0.020
Why?
Bone Diseases
1
1992
21
0.020
Why?
Acute Kidney Injury
1
2014
132
0.020
Why?
Bacterial Vaccines
1
1993
87
0.020
Why?
Anemia
1
2013
119
0.020
Why?
Image Processing, Computer-Assisted
1
2016
654
0.020
Why?
Kinetics
1
1994
751
0.020
Why?
Cell Line
2
1998
1984
0.020
Why?
Precipitin Tests
1
1991
76
0.020
Why?
Chromatography, Affinity
1
1991
48
0.020
Why?
Molecular Weight
1
1991
184
0.020
Why?
Cell Count
1
2011
127
0.020
Why?
Multivariate Analysis
1
2013
902
0.020
Why?
Clinical Chemistry Tests
1
2010
6
0.020
Why?
Decision Making, Computer-Assisted
1
2010
12
0.020
Why?
Osteoclasts
1
2010
47
0.020
Why?
Epitopes
1
1991
286
0.020
Why?
Blotting, Western
1
1991
584
0.020
Why?
Receptors, Cytoadhesin
1
1989
1
0.020
Why?
Receptors, Very Late Antigen
1
1989
1
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
1989
105
0.020
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2009
8
0.020
Why?
Leg
1
2009
85
0.020
Why?
Genetic Predisposition to Disease
1
2013
676
0.020
Why?
Phenotype
1
2013
1137
0.020
Why?
Drug Synergism
1
2009
132
0.020
Why?
Osteoblasts
1
2010
195
0.020
Why?
Antibodies
2
2001
179
0.020
Why?
Safety
1
2009
142
0.020
Why?
Borrelia
1
1988
25
0.020
Why?
Decision Support Techniques
1
2010
179
0.020
Why?
Calcium Oxalate
1
2008
12
0.020
Why?
Bone Remodeling
1
2008
25
0.020
Why?
Fluorescent Antibody Technique
1
1988
217
0.020
Why?
Crystallization
1
2008
97
0.020
Why?
Patient Selection
1
2010
464
0.020
Why?
Receptors, Antigen, T-Cell
1
1989
281
0.020
Why?
Incidence
1
2011
1237
0.020
Why?
Antibodies, Bacterial
1
1988
187
0.020
Why?
Glycosylation
2
1998
129
0.020
Why?
Blood Chemical Analysis
1
2006
21
0.020
Why?
Arm
1
2006
42
0.020
Why?
Lymphocyte Activation
1
1989
743
0.020
Why?
Muscle Weakness
1
2006
29
0.020
Why?
Controlled Clinical Trials as Topic
1
2006
6
0.020
Why?
Seizures
1
2006
113
0.020
Why?
CD4-Positive T-Lymphocytes
1
1989
620
0.020
Why?
Eosinophilia-Myalgia Syndrome
1
2004
1
0.010
Why?
Acanthocytes
1
1983
1
0.010
Why?
Bone Marrow Examination
1
1983
8
0.010
Why?
Leukopenia
1
1983
16
0.010
Why?
In Vitro Techniques
2
1998
471
0.010
Why?
Leukocyte Count
1
1983
97
0.010
Why?
Child
1
1993
4174
0.010
Why?
Dietary Proteins
1
1983
42
0.010
Why?
Dietary Carbohydrates
1
1983
58
0.010
Why?
Disease Susceptibility
1
1983
157
0.010
Why?
Complement System Proteins
1
1983
114
0.010
Why?
Staphylococcal Infections
1
1983
122
0.010
Why?
Attitude to Health
1
1983
279
0.010
Why?
Superoxides
1
2001
69
0.010
Why?
Fas Ligand Protein
1
2001
39
0.010
Why?
Dinoprostone
1
2001
44
0.010
Why?
Intracellular Membranes
1
2001
50
0.010
Why?
fas Receptor
1
2001
55
0.010
Why?
Antigens, Surface
1
2001
192
0.010
Why?
Lysosomes
1
2001
160
0.010
Why?
Propionibacterium acnes
1
1979
6
0.010
Why?
Stress, Psychological
1
1983
442
0.010
Why?
Procollagen
1
1998
10
0.010
Why?
Cytotoxicity, Immunologic
1
1979
147
0.010
Why?
Gastric Mucosa
1
1998
51
0.010
Why?
Epidermal Growth Factor
1
1998
48
0.010
Why?
Spectrometry, Fluorescence
1
1998
90
0.010
Why?
Immunoblotting
1
1998
188
0.010
Why?
Membrane Glycoproteins
1
2001
661
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1998
446
0.010
Why?
Intestinal Mucosa
1
1998
225
0.010
Why?
Glucose
1
1998
445
0.010
Why?
T-Lymphocytes
1
1979
986
0.010
Why?
RNA, Messenger
1
1998
1465
0.010
Why?
Hip
1
1992
7
0.010
Why?
Wrist
1
1992
33
0.010
Why?
Spine
1
1992
42
0.010
Why?
Integrin beta1
1
1989
28
0.010
Why?
CD3 Complex
1
1989
63
0.010
Why?
Antigens, Differentiation
1
1989
137
0.010
Why?
Extracellular Matrix
1
1989
132
0.000
Why?
Ascitic Fluid
1
1979
12
0.000
Why?
Leukemia, Experimental
1
1979
19
0.000
Why?
Mice, Inbred CBA
1
1979
83
0.000
Why?
Cell Separation
1
1979
145
0.000
Why?
Cell Adhesion
1
1979
207
0.000
Why?
Immunity, Cellular
1
1979
171
0.000
Why?
Spleen
1
1979
480
0.000
Why?
Kay's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (522)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_